Duncker Streett & CO Inc Eli Lilly & CO Transaction History

Duncker Streett & CO Inc

$542 Million
Q3 2024

A detailed history of Duncker Streett & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Duncker Streett & CO Inc holds 899 shares of LLY stock, worth $708,582. This represents 0.15% of its overall portfolio holdings.

Number of Shares

899

Previous 892 0.78%

Holding current value

$708,582

Previous $807,000 1.36%

% of portfolio

0.15%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $5,404 - $6,720	7 Added 0.78%	899 $796,000
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $119,624 - $160,040	202 Added 29.28%	892 $693,000
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $525 - $619	1 Added 0.15%	690 $402,000
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $6,313 - $8,441	-18 Reduced 2.55%	689 $323,000
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $234 - $291	1 Added 0.14%	707 $202,000
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $41,147 - $51,064	-183 Reduced 20.58%	706 $195,000
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $86,202 - $106,084	-389 Reduced 30.44%	889 $205,000
Q1 2021 Apr 28, 2021	SELL	$164.32 - $212.72 $32,864 - $42,544	-200 Reduced 13.53%	1,278 $239,000
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $72,927 - $96,500	-559 Reduced 27.44%	1,478 $249,000
Q3 2020 Oct 28, 2020	BUY	$146.22 - $169.13 $43,866 - $50,739	300 Added 17.27%	2,037 $302,000
Q2 2020 Jul 22, 2020	SELL	$136.42 - $164.18 $33,968 - $40,880	-249 Reduced 12.54%	1,737 $285,000
Q1 2020 Apr 27, 2020	BUY	$119.05 - $147.35 $119 - $147	1 Added 0.05%	1,986 $276,000
Q3 2019 Oct 31, 2019	BUY	$106.79 - $116.16 $106 - $116	1 Added 0.05%	1,985 $222,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $44,316 - $51,728	-400 Reduced 16.78%	1,984 $220,000
Q1 2019 Apr 29, 2019	BUY	$111.31 - $131.02 $44,635 - $52,539	401 Added 20.22%	2,384 $309,000
Q3 2018 Oct 22, 2018	BUY	$85.86 - $107.31 $85 - $107	1 Added 0.05%	1,983 $213,000
Q1 2018 Apr 26, 2018	BUY	$74.21 - $87.6 $74 - $87	1 Added 0.05%	1,982 $153,000
Q4 2017 Jan 23, 2018	BUY	$81.94 - $87.89 $81 - $87	1 Added 0.05%	1,981 $167,000
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $152,598 - $169,369	1,980	1,980 $169,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Duncker Streett & CO Inc with notifications on news.

Account

Duncker Streett & CO Inc Eli Lilly & CO Transaction History